We're nearing the end of the calendar-year Q1, with many S&P 500 stocks delivering strong performances year-to-date despite recent volatility stemming from tariff talks and other economic developments.
CVS Health experienced a significant turnaround in 2025, with shares up nearly 50% after a 44% decline in 2024. The recent rally is not driven by great results or strong guidance under new CEO leadership, but rather bad ones that just weren't as terrible as expected. CVS's 2025 outlook includes modest revenue growth, improved operating income, and a focus on stabilizing margins and profitability.
The American stock markets have had a rough month as investors remain jittery over international tariff fears. While this market downturn has affected most sectors of the economy, healthcare stocks are doing exceptionally well, outperforming the general market as the most successful sector of 2025 so far.
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
CVS Health (CVS) closed at $67.20 in the latest trading session, marking a +1.08% move from the prior day.
Instead of blindly buying during a selloff, Jeremy Mullin offers a four-step plan for 2025 to help investors pinpoint stocks and industries that will lead the next leg higher. Learn how to develop a disciplined strategy to capitalize on the market's abundant opportunities.
In the closing of the recent trading day, CVS Health (CVS) stood at $67.91, denoting a +0.5% change from the preceding trading day.
The stock market started strong in 2025, but in recent weeks, news of trade wars and tariffs has hammered the markets. Year to date, the S&P 500 is now down nearly 4.5%, and many investors are worried that there could be further declines coming.
CVS Health Corp. CVS is flashing a bullish signal as it completes a Golden Cross — an event where the 50-day simple moving average (SMA) rises above the 200-day SMA.
CVS Health shares impressive findings from its Weight Management Program.
In the closing of the recent trading day, CVS Health (CVS) stood at $65.75, denoting a +1.4% change from the preceding trading day.
Nearly a third of the U.S. retail pharmacies that were open from 2010 to 2020 had shuttered by 2021, study finds.